Discover Develop Deploy
ANNUAL REPORT2017 - 2018
Discover Develop Deploy
Discover Develop Deploy
CONTENTS
Our vision is to be a recognised
international leader in
accelerating innovation that
transforms citizens’
health and wellbeing.
Foreword 02
AboutHealthInnovationManchester 04
HealthInnovationManchesterjourney 05
Nationalimpact 07
Clinicalresarchexcellence 09
Informaticsandanalytics 11
Healthandimplementation 13
Deliveryprogrammes 16
IndustryPartnerships 23
Industryandwealth 25
EducationandTraining 27
Publicinvolvement&engagement29
OurBoard 31
FinancialReport 33
Discover Develop Deploy
FOREWORD
Positioning Greater Manchester
as an internationally renowned
location for life science, med-tech
and digital healthcare research and
innovation.
WearedelightedtobringyouthefirstannualreportfromHealthInnovationManchester.
2017/2018hasbeenayearofmajortransitionaswebroughtManchesterAcademicHealthScienceCentre(MAHSC)andGreaterManchesterAcademicHealthScienceNetwork(GMAHSN)underthesingleumbrellaofHealthInnovationManchesterinOctober2017.
Despitethechallengesofamajortransition,wehavecontinuedtosuccessfullymaintaintractiononallexistingprogrammes.ThishasbeeninparalleltosecuringanewAcademicHealthScienceNetworklicenceagreementfromNHSEngland,andpreparingforthere-accreditationasanAcademicHealthScienceCentre
Inadditionto‘businessasusual’wehavealsomadesignificantinroadsincreatingkeyinfrastructure,governanceanddecision-makingmechanismscriticaltoinjectinginnovationintothehealthandsocialcaresystem.
ThishasincludedtheformationofthenewHealthInnovationManchesterBoardwhichdrawsonexpertisefromacrosstheNHS,socialcare,industryandacademia;worktoestablishtheInnovation,MonitoringandPrioritisationCommittee(IMPC),whichwillprioritiseandoverseetheinnovationandimprovementworkprogramme,thedevelopmentoftheinnovationpathwaytosimplifythelandscapeforindustryinnovatoions,andpavedthewayfordigitalinteroperabilityandinnovationhubsthatwillimprovethecareweprovidetopatientsnowandinthefuture.
2017/2018hasalsobeenoneofnewcollaborations.In2017wesignedamemorandumofunderstandingwiththeAssociationofBritish
PharmaceuticalIndustries(ABPI)-thefirstofitskindintheUK.Thisisanew,yetalreadyblossomingrelationshipwhichhasledtosometrulyinnovativeprojectsaroundtheeliminationofHepatitisC,pricingmodelsformentalhealthmedication,andimprovingthehealthofCOPDpatients.Someoftheseareoutlinedinourdeliveryprogrammesnapshotonpage16.
WealsohadthepleasureofaddressingseniorrepresentativesfromthepharmaceuticalindustryduringtheABPI’sAnnualConferencewhichhasalreadyyieldedsomeveryinterestingpotentialprojects.
InadditiontotheABPI,wehavealsostartedtheprocessofagreeingasimilarmemorandumofUnderstandingwiththeAssociationofBritishHealthcareIndustries(ABHI).Weexpectthesigningformalitiestobecompletedinthe2018/2019financialyear.
Asillustratedthroughoutthisreport,HealthInnovationManchesterisdeliveringahugeportfolioofprogrammesandprojectsthatwillhave,andarealreadyhavingaprofoundeffect,notjustonthehealthandwellbeingofour2.8mcitizens,butalsonationallythroughourworkwiththeAHSNNetwork(seepage7).
Finally,aswemoveinto2018/2019welookforwardtoforgingnewpartnershipsandcollaborationswithsystemstakeholdersandindustryinnovatorswhiledeliveringadiverserangeofexcitingprogrammesandembeddingthemechanisms,infrastructure,andcultureacrossthesystemtocreateanenvironmentwhereinnovationflourishes-enablingGreaterManchestertobecomeaninternationalleaderinacceleratinginnovationthattransformscitizens’healthandwellbeing.
21
Professor Ben BridgewaterChiefExecuticeOfficerHealthInnovationManchester
Rowena BurnsChairHealthInnovationManchester
Discover Develop Deploy
ABOUTHEALTHINNOVATIONMANCHESTERAsanacademichealthscienceandinnovationsystem,HealthInnovationManchesterisattheforefrontoftransformingthehealthandwellbeingofGreaterManchester’s2.8millioncitizens.
ItwasformedinOctober2017bybringingtogethertheformerAcademicHealthScienceNetworkandAcademicHealthScienceCentreunderonesingleumbrella,whichalsorepresentsGreaterManchester’swiderresearchandinnovationsystem.
HereinGreaterManchester,wehavetheuniqueabilitytodeliverinnovationintofrontlinecareatpaceandscalethankstoour£6bndevolvedhealthandsocialcaresystem,unrivalleddigitalassetsandambitions,exceptionalacademicandresearchcapabilityandthrivingindustrypartnerships.
OurcollectiveambitionistomakeGreaterManchesteroneofthebestplacesintheworldtogrowup,getonandgrowold.
Despitehavingoneofthefastestgrowingeconomiesinthecountry,peopleheredieyoungerthanthoseinotherpartsofEngland.Cardiovascularandrespiratoryillnessesmeanpeoplebecomeillatayoungerageandlivewiththeirillnesslongerthaninotherpartsofthecountry.Ourgrowingnumberofolderpeopleoftenhavemanylong-termhealthissuestomanage.
Therefore,HealthInnovationManchesterhasapivotalroleinbringingforwardaconstantflowoftargetedinnovationsandputtingthemthroughaneffectivebutstreamlinedevaluationprocesssotheyareadoptedatpaceandscaleacrossour10localities.
Wedothisbyharnessingtheassetsofourworld-leadingresearchers,fosteringpartnershipswithindustryandsupportingourNHSandsocialcareproviderstoadoptinnovation,suchasthroughdigitaltechnology,changestopracticeoroptimisingmedication.
In2017/18ourthreebusinessobjectiveswere:
PositioningGreaterManchesterasaninternationallyrenownedlocationforlifescience,med-techanddigitalhealthcareresearchandinnovation.
Acceleratingthediscovery,developmentanddeploymentofinnovationthatimprovesourpopulationshealthandwellbeing
Contributingtonationalandinternationalhealthandlifesciencepolicy.
AlthoughHealthInnovationManchesterisanorganisationwhichdirectlyemployspeople,werepresentresearchandinnovationagenciesworkingacrossGreaterManchester.
ThesuccessofHealthInnovationManchesterisintertwinedwiththesuccessofourpartners,soweworkasonesystem.Thisincludescommissioners,providers,Universities,theBiomedicalResearchCentre,CollaborationforLeadershipinAppliedHealthResearchandCare(CLAHRC),ClinicalResearchNetwork,industry,nationalbodiesandinvestmentagencies.
AnoverviewofoursystempartnerscanbefoundontheHealthInnovationManchesterwebsite.
Asareflectionofthisdynamicsystem,theHealthInnovationManchesterBoardismadeupofleadersfromhealthandsocialcare,academia,researchandindustry.Thisensureswehavesystem-widebuyinofourstrategyandplans.YoucanreadmoreaboutwhotheBoardareonpage29.
TheBoardisunderpinnedbytwomaincommittees–theInnovationPrioritisationandMonitoringCommittee,aswellastheResearchandEducationCommittee.ThesecommitteesalsoincludenominatedrepresentativesfromacrossGreaterManchestertoensurewehavetheagreementandcommitmentfromall.Thissupportsquickerdecisionmakingandspeedsuptheinnovationpathway.
WereceivenationalfundingfromNHSEnglandaspartofourAcademicHealthScienceNetworklicenseandattractconsiderableinvestmentduetoourAcademicHealthScienceCentrestatus.WealsoreceivefundingfromourGreaterManchestersystempartners.Amoredetailedoverviewofourfinancescanbefoundonpage29.
InApril2018HealthInnovationManchesterbecamehostedbyManchesterUniversityNHSFoundationTrust,ensuringourworkisunderpinnedbytherobustgovernance,transparencyandstandardsexpectedofapublicbody.
Contributing to national and
international health and life
science policy.
43
Discover Develop Deploy
2009 2013 2014 2015 2016 2017GreaterManchestersignedaground-breakinghealthandsocialcareagreementtogiveGreaterManchesterandlocalNHSservicesmuchmorecontroloftheregions£6billionhealthandsocialcarebudget.
MANCHESTERACADEMICHEALTHSCIENCECENTRE(AHSC)DESIGNATED
In2013NHSEnglandlicenced15AcademicHealthScienceNetworkstospreadinnovationatpaceandscale-puttinginnovationattheheartoftheNHStoimprovepatientoutcomesaswellascontributetoeconomicgrowth.
ThedevelopmentofAHSNswasrecommendedinSirDavidNicholsonsDecember2011reportInnovation,HealthandWealth
ManchesterbecameoneofsixaccreditedAHSC’sInEngland.TheroleofAHSCwasawardedinrecognitionofdepthandbreadthofclinicalandacademicexcellence.
15ACADEMICHEALTHSCIENCENETWORKSCREATED
GREATERMANCHESTERDEVOLUTIONAGREEMENTSIGNED
LANDMARKAGREEMENTCREATESHEALTHINNOVATIONMANCHESTER
KeyGreaterManchestersystempartnerssignlandmarkMemorandumofUnderstandingtocreateHealthInnovationManchester.
TheroleofHealthInnovationManchesterwastoleveragetheexceptionalassetsofthecityregiontoinpartnershipwithindustrytodriveresearchandprovenInnovationintohealthandsocialcareservicesatpace.
GREATERMANCHESTERDEVOLUTION
Asinglelocallyaccountablebody,theGreaterManchesterHealthandSocialCarePartnershiptookcontrolofpolicyandexpenditureacrossallNHS,populationhealthandsocialcareprovisionforit’s2.8mcitizens.
Thiscreatedtheopportunitytotakeasystem-wideviewofthemostpressinghealthneedsandenabledstreamlinedgovernancearrangementswithjointprovider-commissionerprioritysettinganddecisionmakingatsystemlevel.
HEALTHINNOVATIONMANCHESTERLAUNCHES
GreaterManchesterAcademicHealthScienceNetwork(GMAHSN)andAcademicHealthScienceCentre(MAHSC)cametogetherwithinthecity-regionsAcademicHealthScienceandInnovationSystem-HealthInnovationManchester.
OurJourney
65
Discover Develop Deploy
NATIONALIMPACT:THEAHSNNETWORK
100%
WORKING IN PARTNERSHIPTheAcademicHealthScienceNetwork(AHSN)wasestablishedin2013asaresponsetothe2011Innovation,HealthandWealthreport.
ByconnectingtheNHSwithinnovators,notonlyhastheAHSNNetworkenabledthedevelopmentofsolutionstosomeofthemostchallengingproblemsinhealthcare,ithasalsostimulatedeconomicgrowth.
2017/18markedtheendoftheinitialAHSNlicenseperiod,howevertheOfficeofLifeSciencesiskeentobuildonthesuccessoftheAHSNnetworkandhascommitted£39mtoAHSNsoverthenextthreeyearstoestablishInnovationExchanges(acoredeliverableoftheAcceleratedAccessReview).
Movingforward,theAHSNNetworkwillbedrivenbyninekeyprioritieswhichwillformthebasisfor‘InnovationNationalNetworks’,(INNs),Theseinclude:
InnovationandEconomicGrowth.
InnovationExchange.
MedicinesOptimisation.
MedicalTechnology(MedTech).
DigitalandArtificialIntelligence.
Genomics,AdvancedDiagnosticsandPersonalisedMedicine.
PatientSafety.
QualityImprovement.
Research.
TheINNswillenableaconsistentapproachtodeliveringimpactacrossthe15AHSNs,operatingascommunitiesofexpertise;workingwithstakeholderstoidentifyandshareinnovationsandprioritisethosereadyfornationalspread.TheaimistostimulateconnectionswithinandbeyondAHSNsandinfluencenationalpolicy.
22Patientshave
benefittedromAHSNinput.
MILLION
5.5MILLIONPatientshave
benefitedfromour
PatientSafetyCollaborative
Work.
332INNOVATIONS
Havebeenintroducedandspreadthrough
significantAHSNinfluence.
500JOBSHavebeen
createdasaresultofAHSN
work.
15Peoplehavebenefitted
fromtheNHSInnovation
Accelerator.
MILLION
£42MILLION
Savingshavebeendelivered
totheNHS
MILLIONInvestmenttoimprovehealthandsupportourNHS,care,and
industrypartners
£330
NorthEastandNorthCumbria
Yorkshire&Humber
EastMidlands
Eastern
UCLPartners
HealthInnovationNetwork
Kent,Surrey,Sussex
ImperialCollegeHealthPartners
WessexSouthWest
WestofEngland
Oxford
WestMidlands
InnovationAgency
EastLancashireHospitalsNHSTrustsitswithHealthInnovationManchester
87
Discover Develop Deploy
In 2017 / 2018 we have:
EstablishedtheGreaterManchesterResearchHubtoprovideanintegratedapproachforresearchdeliveryacrossthecity-region.Thisprovidesaone-stopforinterestedpartiestoaccessclinicaltrialsexpertiseandinfrastructure.
DevelopedanenhancedClinicalTrialsUnit(CTU)tosupportthenextgenerationofclinicaltrials(includingrealworldtrials)thataremoreresponsivetotheneedsoftheprivatesector.
CreatedaHealthInnovationManchester-NationalInstituteforHealthandCareExcellence(NICE)DataLab.Linkingdifferentdata-setstogetherandusingstate-of-the-artanalytics,theDataLabistestinghowbigdatacanprovideevidencerelatingtotheeffectivenessofnewandexistingtreatments,andproducenewhealthinsights.
Ledanddeliveredunderpinninginfrastructureinclinicalresearchexcellence,precisionmedicineandacademicinformatics.Thisapproachleverage’sthemaximumvalueofindustry(andother)partnershipstosupportcommercialinwardinvestmentandbusinessgrowthfrombasicresearchtomarketaccess.Wehavealreadyestablished40separatecompanyrelationshipsacrossmultipleareasincludingmajorpharmaceuticalcompanies.
Successfullysecuredcirca£90moffundingincludingNIHRBiomedicalResearchCentre(£28.5m),ClinicalResearchFacility(£12.5m),PatientSafetyTranslationalResearchCentre(£6.67m),gainedCRUKMajorCentreStatus(£39m)andECMCfunding(£2.75m)
LinkedthePatientSafetyCollaborative(PSC)tocuttingedgetranslationalresearchfromourNIHRPatientSafetyTranslationalResearchCentre.Thisenablesustoinfluencelocalpolicy,byensuringpolicymakershaveaccesstorobustscientificevidencearisingfromthelocaluniversitiesofGreaterManchestertoinformhealthandsocialcarestrategieswhichin2017/18includedGreaterManchesterDiabetesandMedicinesOptimisationStrategies.
IncreasedthenumberofNIHRSeniorInvestigators;GreaterManchesternowhasthehighestnumberofNIHRInvestigatorsintheNorthofEngland.
SecuredInnovateManchesterAdvancedTherapyCentreHub(MATCH)£9mawardfromInnovateUKtoestablishoneofthreeAdvancedTherapyTreatmentCentres.
Clinical research excellence
TheGreaterManchesterResearchHub,HealthInnovationManchestersupportsresearchgenerationanddeliverythroughconnectiontostateoftheartresearchinfrastructure,academicexpertise,aresearch-savvyworkforceandstreamlinedprocessesincludingcostingandcontracting.
OurclosecollaborationwithNorthWestEHealthalsoprovidesopportunitiestoempowerthelifescienceindustrytoruncosteffectiveclinicaltrialsfromfeasibilitystudiestofullclinicaltrialmanagementanddelivery.
Inaddition,HealthInnovationManchesterenjoysaproductiverelationshipwiththeGMLocalClinicalResearchNetwork(LCRN)whichisnumberonenationally(allowingforpopulationsize)forrecruitmenttolife-scienceindustryclinicaltrials.Consequently,theGMLCRNisapreferredproviderforanumberofpharmaceuticalcompaniesandContractResearchOrganisations(CROs).
Wearedevelopingapipelineofnewtreatmentsandpathwaysthatwilladdressthehealthneedsofourpopulationinyearstocome.
Throughrecognisedworldleadingexperimentalmedicinestudiesininflammatorydiseasesandcancer,ourpositionasoneofonlythreePatientSafetyTranslationalResearchCentreslinkedtotheNHSIPatientSafetyCollaboratives,andourongoingrelationshipwiththeNIHRCLAHRCinGreaterManchester;HealthInnovationManchesterisideallyplacedtodeliverinnovationthattrulyspansthediscovery-carecontinuum.£47m £39m
Funding awarded for NIHR Research Infrastructure
Awarded as a result of our CRUK Major
Centre Status
ALIGNING CLINICAL RESEARCH TO
SYSTEM NEED AND ACCELERATING THE
LEARNING INTO PRACTICE
100+Events delivered by
our NIHR PSTRC(Patient Safety Translational
Research Centre)
67,500Pharmacy colleagues
accessed our guide on risk management
109
Discover Develop Deploy
UNLOCKING THE VALUE OF
INTEGRATED DATA SYSTEMS ACROSS
HEALTH AND SOCIAL CARE
In 2017 / 2018 we have:
Continuedtheroll-outofDataWellacrossthesystem.12
NHSorganisationsarenowconnectedtoDataWelland
886,563patientrecordshavebeenmapped.DataWellisakey
componentoftheGreaterManchesterDigitalInteroperability
Hub.
WorkedinpartnershipwithsystemstakeholderstoestablishtheGreaterManchesterHealthandSocialCareDigitalBoard.ThisboardisoverseeingambitiousplanstocreateanInteroperabilityHubandInnovationHub.TheInnovationHubwillallowhealthandcareproviderstoexchangedatamoreeasilyandsafelyaccrossall10localities.TheInnovationHubwillenhancehowweusedatatotransformservicesandenableground-breakingresearchandinnovationprojectsthatwillattractindustrypartnersandenableimplementationofchangeatpaceandscale.
SuccessfullysecuredacontractfromNHSEnglandtoworkincollaborationwithOxfordAHSNandArdenandGreaterEastMidlandsCommissioningSupportUnittodevelopaConnectedCareAssessmentTooltoassessplace-baseddigitalmaturity.ThetoolkitwassuccessfullypilotedacrosstwoSustainabilityTransformationPartnerships(STP’s)andawiderrolloutisplannedfor2018/2019.
UtilisationManagementUnitshortlistedfortheHSJValue
Awardinthecategoryofemergency,urgentandtraumacarein
recognitionofthecontributionandchangedrivenbythe100%
challengesthathavebeendeliveredover2017/2018.
Workedwith15hospitalsitestoimproveperformanceagainstthe4-hourAccidentandEmergencytargetforwaitingtimes;resultinginanaverage23.09%improvementinA&Eagainstthetargetaswellasa15%improvementinpatientsatisfaction.
Informatics and analytics
InGreaterManchesterweenjoyaninternationallyleadingpositionintheintegrationofdataandtheuseofreal-worldevidencetodrivepolicy,researchanddeliveryofcare.
HealthInnovationManchesterisbuildingonthesestrengths,joininguphealthandsocialcareinformationsothatwecancreate:
Aregion-widelearninghealthsystemthatoptimisesthedeliveryofcarebasedoncontinuoussystemevidence.Thisincludesanearreal-timeviewofhealthcareutilisationtoensureweoptimisecarepathwaysandvalueformoney(UtilisationManagement).
Data-richobservationalstudies,precisionmedicinecapabilityanddiscoveryscience,trialsandeconomicevaluationsofmedicinesanddevicesaswellasotherinterventionsthatcanbeundertakenacrossthepopulationquicklyatlowcost.
Ourreputationhasalsoattractedinterestanddemandnationallyandinternationally.In2017/2018ourUtilisationManagementUnitcompletedcommissionsfromthewiderhealthcaresystemsparticularlyinrelationtourgentandemergencycare-generatingover£1minrevenuetoinvestbackintothesystem.
886,563 1in 3Thousand records are now mapped within
DataWell
NHS organisations in GM are now connected to
Datawell
86%Of GM leaders that
recieve UM analytical reports use them
daily
£1m+Revenue generated
by the Utilsation Management Unit
this year
1211
Discover Develop Deploy
TRANSFORMING THE HEALTH AND
WELLBEING OF OUR 2.8M CITIZENS
In 2017 / 2018 we have:
WorkedcollaborativelywiththeAtrialFibrillation(AF)AHSNnetworktodelivernationalandlocalimprovementsaroundAFmanagementanddetection.Thishasalreadypreventedanestimated13strokesinGreaterManchesterandresultedin468patientsbeingofferedtreatmentwithspecialistpharmacists,andwherenecessaryassessmentinprimarycare.
DeliveryofthefirstAtrialFibrillationCCGpharmacy-ledanticoagulationclinicwhichidentified6,059patientsacrossthecityofManchesterwitha‘readcode’ofatrialfibrillation.Ofthese1,603patientswere‘knownnottreated’whichequatesto52expectedstrokes.Wearenowfundingawork-streamin2018/19totacklethis.
DeploymentofERAS+,apre-andpostoperativesurgeryprogrammetooptimisepatientrecovery.Implementationatonetrusthasreducedpost-surgerypulmonarycomplicationsby50%resultingina3dayreductioninlengthofstayandannualsavingsofover£0.5m.A£500kgrantawardhasbeensecuredfromtheHealthFoundationtotakethisworkforwardincludingtheroll-outacrosssixtrustsinGreaterManchester.
DeliveredacontroltrialofaTroponin-onlyManchesterAcuteCoronarySyndromes(T-MACS)decisionaidtoolthatwasdevelopedinGreaterManchester.ThishasalreadyresultedinabenefittopatientssuspectedofAcuteCoronarySyndromeandfinancialsavings.ThisisnowbeingdeployedacrossGreaterManchesterandthewiderUK.
DeliveredthefirstRainbowClinic-aspecialistserviceforwomenandtheirfamiliesinasubsequentpregnancyfollowingastillbirthorperinataldeath.Thishasalreadybenefited140families,prevented9like-for-likestillbirths(Contributed2.19%oftheavoidedstillbirthsnationwideduringoperation)andhasgeneratedan8foldreturnoninvestment.ThisisnowbeingdeployedacrossGreaterManchester.
IncorporatedPINCER:(pharmacist-ledinformationtechnologyinterventionformedicationerrors),anauditsoftwarepackagewhichhelpsGPpracticesreviewpatientcaseloadsandhighlightpatientswhomaybeatriskofprescribingerrorsintoGMPrimaryCareMedicalStandards.Thisisresultinginareductioninmedicationsafetyincidentsandreducingunwarrantedvariation-improvinghealthoutcomesforourpatientpopulation.
Health and implementation
HealthInnovationManchesterisdeliveringalargeanddiverserangeofprojectsinpartnershipwithindustry,healthandsocialcarecommissionersandproviders,andthenationalAHSNNetworkto:
Improvehealthoutcomesacrossthe
HealthInnovationManchesterfootprint
throughthesystematicreductionofthe
numberofdeaths.
Spreadatpaceselectedinnovationsthat
willimprovethehealthofthepopulations
weserveandcreateasustainableAHSNfor
GreaterManchester.
Createaclimateandsupporting
infrastructureforentrepreneursand
innovatorstodevelopideaswithinthe
NHS,therebycreatinghealthandwealth.
Supportourmembersandstakeholdersin
theirrelatedprioritiesandambition.
Over2017/2018wehavebeenprogressing
projectsacrossamultitudeofareas,which
includecardiovasculardisease(CVD),
mentalhealth,emergencymedicine,cancer,
respiratoryandnationalAHSNprogrammes
-manyofwhicharehighlightedin‘current
deliveryprogrammes’onpages16to22
Themanagementteamalsoworksvery
closelywiththePatientSafetyCollaborative
Team,withbothareassynergisingprojects
wherethereismerit.
9 13 £500k £8kStillbirths have been
prevented by the Rainbow Clinic
Estimated number of Strokes prevented by
the AF programme
Savings at one hospital trust
implementing ERAS+
Potential medicine reimbursements at 2
hospital trusts
1413
Discover Develop Deploy
PROJECTS
OVERVIEW
A brief overview of some of the 50+ projects being delivered by Health Innovation
Manchester over 2017/2018 that will continue into 2018/2019
Accelerating the discovery,
development and deployment
of innovation that improves
our population’s health and
and wellbeing.
1615
Discover Develop Deploy
CURRENTDELIVERYPROGRAMMES
IMPROVING CARE FOR PEOPLE WITH COPD
HealthInnovationManchesterisworkingwithhealthandindustrypartnerstodevelopandimplementanambitiousplantoradicallyimprovethecareandtreatmentofpeoplewithCOPDacrossthe10localitiesofGreaterManchester.
COPDisthefifthbiggestkillerintheUK.PatientswithCOPDsufferwithseverebreathingdifficulties,oftenresultinginhospitalisation.Therearearound67,000patientsdiagnosedwithCOPDlivinginGreaterManchesterandtherearelikelytobehundredsmoreunknowinglystrugglingwiththedisease.
ThecostofmanagingCOPD-relatedhospitaladmissionsandmedicationsforGreaterManchesterisaround£73millioneachyear,withfurtherindirectcostsestimatedtobeasmuchas£1.8
billion.Infact,thecity-regionhasthesecondhighestadmissionratesforCOPDinEngland,aswellaspooroutcomesandunwantedvariationbetweenGPPracticesandlocalities.
Theprogrammebuildsontheground-breakingSalfordLungStudy,whichexaminedthesafetyandefficacyofnewmedicationstotreatrespiratoryillness.
Thiswastheworld’sfirstdigitallyenhancedrandomisedreal-worldtrialtoincludeabroadandinclusivepopulationofpatientsinaneverydayclinicalpracticesetting-madepossiblebythesingleelectronicmedicalrecord.
TheaimoftheCOPDprogrammeistoimprovethehealthofCOPDpatientsthroughclinicallyappropriateandcost-
effectivetreatmentusinginhalers.Thiswillbeachievedthrough:
Reviewingpatients’existingtripletherapyprescribingtoidentifythosewhocansafely‘stepdown’fromthecorticosteroidelementoftheirmedication,
ReviewingpatientsreceivingmedicationwhichisnotinlinewiththelatestGreaterManchesterMedicinesManagementGroup(GMMMG)guidelinestoenablepatientstoswitchtorecommendedalternativeswhereclinicallysafetodoso.
ELIMINATION OF HEPATITIS C
GreaterManchesterhastheambitiousaimtobecomethefirstUKcityregiontoeliminateHepatitisCby2021.
Thevirus,whichaffectstheliver,cansometimescauseseriousandpotentiallylife-threateningdamageifleftuntreated.
Thereareestimatedtobearound17,450peopleinGreaterManchesterlivingwiththeinfection,includingaround7,000whoareundiagnosed.Ofthosediagnosed,only28%areengagedwithspecialistservices.
TheHealthInnovationManchester
projectaimstoeliminateHepatitisCbyusinganetworkedandphasedapproach.
Communitypharmacieswilldeliverpointofcaretestinganddrybloodspottestingtomaximisethenumberofpeopletestedandidentifyhighriskpatientsaswellasprovidingtreatmentinamoreconvenientlocationfortheindividual.
Pharmacieswillbetargetedintermsofmethadonedispensingandopiatereplacementtherapyaswellasthoseoperatingasafeneedleexchange.
Followinganinitialpilot,theprojectwilllooktotestandtreatthewiderpopulationgroupsathighriskofinfectionandarapidtestingandtreatmentregimewillalsobeimplementedforthoseinorenteringprison.
Theprojectaimstobringspecialistservicestothepatientatthepointofneedanddevelopanew,morecost-effectivetestingandtreatmentinfrastructure.Itwouldalsoresultinareductioninassociatedhealthcarecostsandabetterqualityoflifeforpatients.
ERAS+ ENHANCED RECOVERY AFTER SURGERY
PatientsundergoingsurgeryatsixGreaterManchesterhospitalswillbepreparedfortheexperienceinthebestpossiblewayusingtheEnhancedRecoveryAfterSurgery(ERAS+)programme.
Thesurgicalpathwaybuildsonthesuccessofthein-hospitalprogrammebutexpandsittoincludesixweeksofpre-surgerypatientpreparationandpost-hospitalrecoverysixweeksafter,withpatientsandtheirfamilysupportedthroughaSurgerySchool.
Therearearound250,000high-riskelectivemajorsurgeriesayearinEnglandandWalesandthereisapost-operative
pulmonarycomplicationrisk(PPC)ofupto30%.Complications,suchrespiratoryfailureorpneumonia,canincreasethelengthofstayinhospitalandreducelifeexpectancyaftersurgery.
TheERAS+programmeplacesthepatientatthecentreoftheirownrecoveryandsupportsthemtobedynamicintheirowncare.Itencouragesincreasedactivity,betternutrition,oralhealthcareandthepracticeofchestexercisestohelpreducechestproblems.
Itaimstoreducecomplicationspost-surgery,withevidencesuggestingareductioninpulmonarycomplications
by50%,reducethelengthofstayinhospitalbyaroundthreedaysandimprovequalityoflifeforpatientsforsixto12monthsaftermajorsurgery.
TrustsparticipatinginERAS+areManchesterUniversityNHSFoundationTrust,StockportNHSFoundationTrust,BoltonNHSFoundationTrust,ThePennineAcuteHospitalsNHSTrust,SalfordRoyalNHSFoundationTrustandTheChristieNHSFoundationTrust.
HEALTHY HEARTS: SYSTEMATIC IDENTIFICATION OF HIGH-RISK CVD PATIENTS
HealthyHeartsisaninnovativeprogrammeaimingtoreducedeathsfromCardiovascularDisease(CVD)throughbetteridentificationofthoseatriskofheartattackorstrokeinGreaterManchester.
TheprojectwillworkcloselywithClinicalCommissioningGroupstofindthoseathighestriskofCVD,includingthosewithhighbloodpressureandhighcholesterolinasystematicandtargetedapproach.Theprogrammewillalsolinkwithtargetedhealthchecksandlifestyleinterventions.DatashowsthatifeachCCGintheareareachedthelevelofthe
fivebestsimilarCCGs,therewouldbe356fewerdeathsforunder75-year-oldseachyear.
Itisestimatedthatidealcontrolofdiagnosedhypertensives–thosepatientswithhighbloodpressure–couldsave470heartattacksand700strokesoverthreeyearsinGreaterManchester,afinancialsavingofover£13.2million.
TheprojectaimstoreducedeathsfromCVDbyatleast600by2021andidentifythoseathighestriskofCVDtoenabletreatment,lifestyleinterventionsand
self-managementopportunities.HealthInnovationManchesterhasalsoprovidedpracticesinGreaterManchesterwithaccesstotheAliveCorKardiahand-heldAtrialFibrillation(AF)detectiondevicetoimprovecareforpeoplewithAFandreduceAF-relatedstrokes.
ThemobileECGdeviceshelpwiththedetectionofpeoplewithAFinclinicaland/orcommunitysettings.
1817
Discover Develop Deploy
CURRENTDELIVERYPROGRAMMES
GREATER MANCHESTER & EASTERN CHESHIRE PATIENT SAFETY COLLABORATIVE
Safetyandensuringpatientsarenotharmedwithinahealthandsocialcaresettingiseveryone’sresponsibilityandGreaterManchesterisinauniquepositiontobeabletosupportandcreateasmoothpathwaytoimprovement.
ThroughthePatientSafetyCollaborative,ajointinitiativefundedandcoordinatedbyNHSImprovementanddeliveredbyHealthinnovationManchester,wecanworkdirectlywithlocalteams,supportingthemtomakesuretheyhavetherightskillsandresourcestoimplementimprovements.
Wecanalsosharegoodpracticeacrossthehealthsystem,focusonpeople-centredcareandbuildrelationshipswith
NHSstaff,businessandacademiatostimulateinnovationandimprovement.ThePSCwillfocusonthreenationalareasofwork:
DeterioratingPatients:Toreduceharmandenhancetheoutcomesandexperienceofpatientswhoaredeteriorating.
CultureandLeadership:Tohelpcreatetheconditionsthatwillenablehealthcareorganisationstonurtureanddevelopacultureofsafety.
MaternityandNeonatal:Toimprovematernityandneonatalcare,specificallyreducingtherateofstillbirth,neonataldeathandbraininjuriesoccurringduringorsoonafterbirthby20%by2020.
ThePSChasbeensetuptosupport,connectandprovideinitiativesandactivitiestodriveimprovementandensurepatientsafetyisembeddedthroughouttheGreaterManchesterhealthandsocialcarecommunity.
RAINBOW CLINIC: SPECIALIST ANTENATAL SERVICE
Becomingpregnantagainafterastillbirthisanincrediblydauntingprospectforwomenandfamilies,oftencharacterisedbythefearofrepeatingtheexperience.
Womenwhohavehadastillbirthareatincreasedriskofcomplicationsinsubsequentpregnancies,includingstillbirth,pre-eclampsia,placentalabruptionandlowbirthweight.
Itisalsoassociatedwithincreasedpsychological,emotionalandsocialchallenges.
TheRainbowClinic,atSaintMary’sHospital,isaspecialistservicefor
womenandtheirfamiliesduringasubsequentpregnancyfollowingastillbirthorperinataldeath.
Itcaresforfamiliesfromthetimeofthepostnatalappointmentonwardsandintoasubsequentpregnancy.
Itengageswithwomenearly,ensuringtheyareontherighttreatment,makinganynecessaryreferralsandprovidingmoredetailedultrasoundscanning.
Theadditionaltestsandcontinuityofcare,providedbyasmallteamofspecialistdoctorsandmidwives,resultinimprovedoutcomesforthebabyaswell
asimprovedpsychologicalwell-beingforparentandbetteruseofNHSresources.
HealthInnovationManchesterwillsupportthescale-upacrossGreaterManchestermaternityunits,aimingtoreducetheratesofmaternaldeaths,stillbirths,neonataldeathsandbraininjuriesthatoccurduringorsoonafterbirthby20%by2020andthenby50%by2030.
ThecharityTommy’sisalsogivingadditionalfinancialsupportasvalidationoftheclinicalprogresstoensurescaleandspreadoftheproject.
REDUCTION OF FRAILTY-RELATED FALLS AND FRACTURES
Forolderpeoplelivingwithfrailty,afallorfracturecanresultinarapiddeteriorationinhealthandsignificantlossofindependence.
Thereareapproximately65,000hipfracturestakingplaceintheUKeachyear,costingthehealthandsocialcaresystemaround£2billion.Itisimperativethatsystemsareinplacetohelpidentifypeoplewhoareatriskoffallsandfracturestoensurethereareappropriatetreatmentandservicesthatmeettheirneeds.
TheHealthInnovationManchesterprojectaimstoreducefallsandfracturesrelatedtofrailtyacrossGreaterManchesterthroughearlyintervention,treatmentandmanagementofat-riskpatients.
Theprojectwillsupportprimarycarebyfindingat-riskpatientssothatthey
canbetreatedwithappropriatebone-sparingtherapies,includingmedicationtostrengthenbones,andsupportedwithservicesinthecommunitytohelpmanagetheircondition.
Throughearlyandincreasedidentificationofosteoporosisandotherhigh-riskfactors,theestablisheduseoffractureriskassessmenttoolsinprimarycareaswellaspatientbehaviouralandlifestylechangesthrougheducationprogrammes,itishopetherewillbeareductioninfracturesandassociatedcosts.
PhaseoneisbeingundertakeninTamesideandGlossopLocalitywiththeDukinfield,StalybridgeandMossleyFrailtyMultidisciplinaryTeam(MDT)pilotlaunchedon31January2018.
Ithasbeensetupasavehicletosupporttheidentification,reviewand
managementofseverelyfrailpatientsusingtheelectronicFrailtyIndexandfractureandfallsriskassessmentITtools.
OnceapatientisidentifiedasbeingseverelyfrailtheMDTmembersdiscussandagreeonasetofappropriateoutcomesandactionstosuittheneedsofthepatientwhichcanincludeseveralclinicalandnon-clinicalinterventions.
Thismayincludereferralstocommunitygroups,physiotherapy,CommunityResponseService,Extensivistservice,socialprescribing,prescriptionofbonestrengtheningmedication,etc.
EightweeksaftertheMDTmeetingafollowupiscarriedouttoensurethatallagreedoutcomesandactionshavebeenachieved.
MENTAL HEALTH PRICING REVIEW MODEL
HealthInnovationManchesteraimstodemonstrateinnovationinthefieldofmentalhealththroughthetestingofanoutcomesbasedpricingmodelforschizophreniatreatments.
Second-generationantipsychotics(SGAs)representanadvanceinthelong-termmanagementofschizophrenia,particularlyregardingextrapyramidalmotorsafetyandsubjectivetolerability.
However,theevidencethatthemedicationsareeffectiveformaintenanceandstabilityislimited.
Asarelapseinschizophreniacancostbetween£12,000and£25,000,industry
partnerJanssenhavedevelopedanoutcomespaymentschemeandrebatetodemonstratetheirbeliefthattheirmedicinescanplayaroleinpreventingrelapseandthekeycostthatgoeswithit.
WorkinginpartnershipwithHealthInnovationManchester,JanssenofferedMentalHealthTrustsinGreaterManchesteraccesstotherebateschemewhichreimbursestheproviderifthetreatmentdoesn’tworkasplanned.
Theschemeproposesarefundforthecostoftheinjectionshouldtheperson,prescribedtheinjection,failtoachievetherequiredoutcome.
The scheme has provided real-world data as to whether the second-generation antipsychotic injections prevent relapse and admission as well as potential financial savings of £10,000 against medication costs for 2017, with the scheme in place for two trusts until June 2021.
The anticipation is that the tracking of the patient journey and understanding discontinuation and relapse will lead to better care with improved outcomes.
2019
Discover Develop Deploy
CURRENTDELIVERYPROGRAMMES
DEMENTIA
GreaterManchesterisaimingtobe“thebestplacetolivewithdementiaintheworld”andHealthInnovationManchesteriscommittedtosupportingworktowardsthisvision.
Itisestimatedthattherearecurrentlyover30,000peoplelivingwithdementiainGreaterManchesterwiththecityregionspending£270millionayeartreatingandcaringforpeoplewithdementia.
Withanageingpopulationandrisingnumbersofpeoplebeingdiagnosedwithdementia,itisoneofthegreatesthealthchallengesfacingthecountryandGreaterManchester.
TheDementiaUnitedOperationalGroupareworkingwithpartnersacrossGreaterManchestertoimprovetheexperiencesofpeoplewithdementiaandtheircarers,andreducepressureonthehealthandsocialcaresystem.
HealthInnovationManchesterwillsupportDementiaUnitedthroughtheidentificationandimplementationofsuitablenewinnovationstosupporttheoverallobjectives.
Workinginpartnershipwithindustry,HealthInnovationManchesterwilldeliveranearlydetectionanddiagnosticsframeworkfordementia–buildingontheprinciplesofpre-empt
andpreventtodetectandinterveneeveryearlyinthepathwayofcognitivedecline.
Thevisionistoimproveoutcomesbyensuringoptimalaccessanduptakeofinnovativetechnologiesandtreatmentsforeligiblepeople,aswellasensuringthehealthandcaresystemisgearedtoprovidethebestsupportforpeoplelivingwithdementia.
T-MACS: TROPONIN ONLY MANCHESTER ACUTE CORONARY SYNDROMES DECISION AID
Patientspresentingwithchestpainattheemergencydepartmentarethegroupmostcommonlyrequiringhospitaladmission.Troponinsareafamilyofproteinsfoundinheartmusclesthatproduceamusclecontractionwithserialtroponintestingremainingthestandardofcaretoruleoutheartproblems.
TroponinonlyManchesterAcuteCoronarySyndromes(T-MACS)isadecision-aid,acomputerisedclinicalpredictionmodelwhichcalculateseachindividualpatient’sprobabilityofacutecoronarysyndromesfollowingasinglebloodtestatthetimeofarrival.Thisprobabilityisusedtoassigneachpatient
totherelevantriskgroupandsuggestacourseofactionforthecliniciantofollow.
SinceimplementationatManchesterRoyalInfirmary,over3,500patientshavebeentreatedusingT-MACS,withthealgorithmprovingsuperiortoNICEguidelines.
Morethantwo-thirdofpatientscanbetreatedinanambulatorycaresetting,suchasoutpatientclinicsoremergencydepartments,withthevastmajoritydischargedonthesameday,comparedtoatwo-dayaveragestaywithroutinecare.
T-MACSwonManchesterFoundationTrust’sTransformationPrizein2016andHealthInnovationManchesteraimtoimplementitacrossGreaterManchestertoincreasethequalityandefficiencyofhealthcareprovidedtopatient.
Theprojectcouldresultinimprovedqualityoflifeforpatients,duetoquickerandmoreeffectivediagnosisandtreatment,moreappropriatetriagingofpatientsandisprojectedtosave£100millionperyearifrolledoutacrosstheNHS.
QUALITY IMPROVEMENT - LIFE QI AND THE Q COMMUNITY
HealthInnovationManchestersupportsasystem-wideapproachtodrivingqualityandimprovementandoffersafreetooltohealthandsocialcareorganisationsacrossGreaterManchester.
LifeQIisaweb-basedplatformdesignedtoassistfrontlinestaffrunningQualityandSafetyimprovementprojectsandconnectwithacommunityacrossthecountrytosharebestpractice.
Thetool,developedaspartofthePatientSafetyCollaborativeinpartnershipwithSeeData,supportsfrontlineNHSandsocialcareteamstoplan,monitorandreportprogressoftheirimprovementprojects.
TheflexibleLifeQIapplicationcontainstoolstohelpimprovementworkandmakeiteasytoseeprogress.Itallows
teamstocreatedriverdiagrams,conduct“Plan,Do,Study,Act”(PSDA)cyclesandvisualiseresultsthroughcharts,aswellascreatingabankofQIprojectswhichcanbeshared.
UserscanalsoconnecttoaQIcommunityofpracticeacrossthecountry,encouragingcollaborationwithteamsworkingonsimilarchallenges,avoidingduplicationandsharinglearningandsuccesswhilebuildinganetworkofpeoplecommittedtoimprovingcare.
Morethan140peopleandorganisationsworkingonserviceimprovementprojectshavealreadysigneduptotheLifeQItoolthroughHealthInnovationManchester.
HealthInnovationManchesterhasalsopartneredwithAdvancingQuality
Alliance(AQuA)andTheHealthFoundation’sQCommunityfortheQBookClubevents.
TheQcommunityisaninitiativeconnectingpeoplewhohavehealthandcareimprovementexpertiseacrosstheUKwithopportunitiestoshareideas,enhanceskillsandcollaborate.
TheQCommunityBookClubwillfeaturefivesessionswhichwillexaminekeyqualityimprovementliterature,hearfromlocalandnationalimprovementleadersandexploreonlinetoolstohelpQcommunitymemberssharediscussionandapplylearning.
GREATER MANCHESTER BIOLOGICS OPTIMISATION - VIRTUAL BIOLOGICS CLINIC
HealthInnovationManchesterissupportingasystem-wideapproachtoreducingunnecessarywastageofhigh-costbiologicdrugsacrossGreaterManchester.
Currentlythereisasubstantialspendingonapprovedbiologics,aclassofmedicationthatisnotsynthesizedchemicallybutinsteadharvesteddirectlyfrombiologysuchasenzymesorantibodies,withanestimated£45-50millionspentacrossGreaterManchester.
Alongsidethishighspend,thereareloosegovernancearrangementsfortheiruse,withpoormechanismsinplaceto
adequatelytrackandrecordusage.AVirtualBiologicsClinic(VBC)wascreatedatManchesterRoyalInfirmaryinordertoensurethattheprescriptionofbiologictherapieswasbasedprimarilyontheneedsofpatientsandnotoncostandtoincreasethespeedatwhichpatientscouldgainaccesstothetreatmentandprovidemoreopportunitiesforpatientstoparticipateinclinicalresearch.
TheVBCeffectivelyimplementedapan-ManchesterbiologicspathwayinRheumatologyatMRIwiththeinnovationschangingthedepartment’sprescribingpatternsandincreasing
researchrecruitment.Italsoincreaseddepartmentalefficienciesandgeneratedcostsavingsthroughhigheruptakeofcheaperbiologicstherapies.
DevelopingaVBCandbiologicoptimisationinitiativesinallGreaterManchesterTrustswouldcreateaneffectivewayofdeliveringbiologicsforpatientsinthemostcost-effectiveway.
2221
Discover Develop Deploy
In 2017 / 2018 we have:
BroughttogetherManchesterAcademicHealthScienceCentre(MAHSC)andGreaterManchesterAcademicHealthScienceNetwork(GMAHSN)intoasingleorganisation-HealthInnovationManchester.Thisbringstogethertheentirediscovery-carecontinuumfromresearchtoimplementationundertheumbrellaofasingleentity;workinginpartnershipwithindustrytodriveresearchandinnovationthatisalignedtohealthandsocialcareneeds.
DevelopedasingleinnovationpathwayfortheentireGreater
Manchesterhealthandcaresystem-simplifyingthelandscape
forresearchersandindustryinnovators.Thissystematic
approachensuresthatthesystemhasabalancedpipelineof
innovationalignedtothecityregion’sneeds,andamorerapid
andassuredjourneyforinnovationsfromdiscoverythroughto
deployment.
BeganestablishingtheInnovationPrioritisationandMonitoring
Committee(IPMC);asub-CommitteeoftheHealthInnovation
ManchesterBoardmadeupofstakeholdersrepresentingthe
wholesystemwhoseremitistoprioritiseandoverseethe
innovationandimprovementworkprogrammeacrossthe
GreaterManchesterhealthandsocialcaresystem.Thisensures
system-wideengagementpriortosystem-widecommissioning.
SignedtheUK’sfirstMemorandumofUnderstandingwiththe
AssociationofBritishPharmaceuticalsIndustry(ABPI).This
articulateshowtheGreaterManchestersystemwillwork
collaborativelywithpharmaceuticalcompanies.Despite
itsinfancythishasalreadyledtosomeveryinnovative
partnershipsacrossareassuchasCOPD,HepatitisC,virtual
biologicsandmentalhealth.
LaidthegroundworkforaMemorandumofUnderstanding
withtheAssociationofBritishHealthcareIndustries(ABHI).
Thiswillbesingedin2018andenableustodriveforward
partnershipworkingwithmedicaltechnologycompanies.
Industry partnerships
GreaterManchesteristheonlycity-regioninEnglandwithcontrolofitscombinedhealthandsocialcarebudgets.
AsingleaccountablebodywithdelegatedresponsibilitiesnowcontrolspolicyandexpenditureacrossallNHS,populationhealthandsocialcareprovisionforits2.8mcitizens.
Thishascreatedauniqueandexcitingopportunitytotakeasystem-wideviewoftheregion’smostpressinghealthneeds;joininguptheworkofallhealthandsocialcarecommissionersandproviderstomeettheseneedsinthemostefficientandcost-effectiveway.
Empoweredbythishealthandsocialcaredevolution,HealthInnovationManchesterisprovidingamuchsimplifiedlandscapeforresearchersandindustryinnovators.
Thisincludesasinglegatewayintothesystemwithasingleinnovationpathwaythatcapitalisesonthecityregion’sstreamlinedandaccelerateddecision-makingstructures;providingindustryinnovatorswithanenhancedlevelofassuranceandspeedierdecision-makingintermsofadoptionfollowingproofofconcept.
200 66%AliveCor devices
deployed accross the GM system
of GM Maternity sites have adopted the
Episcissors-60
40 Months from Relvar
Ellipta phase III clinical trial to
adoption in GM
1st UK Memorandum of Understanding with the Pharmaceutical
Industry
CREATING A SIMPLIFIED
LANDSCAPE FOR INDUSTRY WITH MORE ASSURED
ROUTES TO ADOPTION AND
SPREAD
2423
Discover Develop Deploy
SUPPORTING INDUSTRY TO
TAKE INNOVATIVE PRODUCTS AND
SERVICES INTO THE LIFE SCIENCES
MARKET
In 2017 / 2018 we have:
Provided£26,000fundingacross2organisationsforearlystage
developmentofinnovativesolutionsviaour’Ignite’funding
call.
Distributedupwardsof£98,000fundingtosupportmarket
readyproductsandservicesthroughour‘Momentum’funding
call,resultinginadditionalleveragedfundingof£500,000
(venturecapital).
Providedassistanceandsupporttoover108industry
innovatorsviaourawardwinningInnovationNexus;providing
information,accessandsupporttodevelop,test,anddeliver
innovativeproductsandservicesincollaborationwiththe
healthandsocialcarecommissionersandproviders.
WorkedcollaborativelywithNICEtodevelopamedical
technologyearlytechnicalassessment(META)gapanalysis
tooltohelpproductdevelopersunderstandwhatevidence
isrequiredtomakeaconvincingcasetopayersand
commissionersabouttheirtechnology.
DeliveredtheStepIntoHealthprogrammeto3cohortsof
30companiestohelpthemimprovetheirproductpitchand
increasetheirchancesofprocurementandsuccessinthelife
sciencesmarket.
Deliveredaregionaldigitalhealthacceleratortargeting
innovativedigitalhealthbusinesses;providingsuccessful
applicantswithopportunitiestoengageclinicalandhealthcare
expertiseandNHSprocurementsupport,aswellashelping
themunderstandthehealthsystemanditsneeds,develop
theirbusinessmodels,andrefinetheirpropositions.
ActedastheleadpartnerontwoSBRIcallsforreducing
pressureonurgentandemergencycareandimprovedcancer
diagnosis;definingtheclinicalneedandprovidingbusiness
assessors.
Engagedwithupwardsof111companiesthroughtheEuropean
RegionalDevelopmentFund(ERDF)Programme
Industry and wealth
HealthInnovationManchesterisactivelytargetinginnovationsthatspanthehealthandsocialcarespectrum;boththosethatrequiretrialling,orhavealreadybeentrialledandthosewhichrequiresystem-wideadoption.
InGreaterManchesterwehaveanintegratedinnovationpathwaythatmaximizesthebenefitsofourlocalecosystemtoentrepreneursandallowsthemtoaccesstheadvice,fundingandpartnershipsthatwillbeessentialfortheirsuccess.
CentraltothedeliveryoftheInnovationPathwayhasbeenthedeliveryandon-goingdevelopmentofHealthInnovationManchester’sInnovationNexuswebportalandadvisoryservice,thewinneroftheNorthofEnglandBusinessServiceawardsin2016.
TheInnovationNexusenablescompaniestolodgeenquirieswithanintelligentinterfaceandreceiveeithersignpostingand/orguidance,orwhenappropriate,follow-onsupportservicestoassistwithprogressionthroughthedevelopmentpathway,fromearlystageclinicalengagement,toassistancewithadoptionandprocurementintotheNHS.
Overthepastfinancialyear,HealthInnovationManchester haS also been delivering a matchfundedEuropeanRegionalDevelopmentFund(ERDF)programmeineasternCheshire.
This has involved working with SME’s withinnovative products and services to providesupporttoworkwiththeNHSandgrowtheirbusiness.
£4.29m 402 383 £1m+Leveraged funds
have been secured in 2017/2018
Enquiries recieved via the Innovation
Nexus since its launch
Companies assisted via the Innovation
Nexus since its launch
Innovation grants awarded since the Innovation Nexus
launch
2625
Discover Develop Deploy
EMBEDDING THE SKILLS
AND CREATING THE CULTURE
WITHIN THE GM WORKFORCE TO
INNOVATE
In 2017 / 2018 we have:
ExpandedourMResinCancerExperimentalMedicineto
includeallthemesofourBiomedicalResearchCentreand
therebybuildexperimentalmedicinecapacitymorebroadly.
Furthermore,wehavecontinuedtorecruitsuccessfullytoour
comprehensivesuiteofprogrammesinHealthDataScience,
BioinformaticsandGenomicsthatrangefromaccreditedshort
coursestoMSc/PhDlevels.Accreditedcomponentsofthe
aboveprogrammescoupledwithspecialtyspecificmodules
canbecombinedintoflexiblepostgraduateprogrammesfor
clinicaltrainees.
DeliveredanewcollaborationbetweenwithTheRoyalCollegeofPhysiciansofEdinburgh(theRCPE)throughtheopeningofanofficeinManchester(RCPEManchester)inJune2017.TheRCPEiscommittedtopromotingthehighestclinicalstandardsandtheimplementationofrobust,evidence-basedmedicalpractice.TheRCPEhashostedanewseriesof‘hottopic’eventsandinternationalconsensusconferences,developingblendedlearningopportunitiesandco-badgedpostgraduatequalificationsandtherebyincreasinglocaltrainingandCPDopportunities.TheRCPE’sexistingnetworkofnationalandinternationalcentreswillbeusedtolive-streameducationalandtrainingeventsaroundtheworld.
DeliveredaOneManchesterTranslationalResearchTrainingDaywhichwasattendedbyover100PrincipalInvestigators,ResearchNursesandResearchProgrammeManagers(RPMs)fromacrossGreaterManchester.
DesignedanInnovativeDevelopmentalFrameworkthathasbeenpilotedbyourResearchProgrammeManagerNetwork(over130members)whichspecifiescompetencystandardsforeachleveloftheirappointment.
DeliveredaClinicalBioinformaticsMassiveOnlineOpenCourse(MOOC)designedtoprovideskillstohealthcareprofessionalstoenabletheanalysisandinterpretationofgenomicdata.Thishasattractedover13,000participantstodatefromacrosstheworld.
Education and training
GreaterManchesterisacityunitedthroughpartnershipsestablishedforthebenefitofourpopulationandourlocaleconomy.
Asaregionofhighdiseaseburdenandhealthinequality,itisessentialthatourcitizensreceivethehighestqualityhealthandsocialcareprovision,deliveredbyahighlytrainedworkforceofhealthandsocialcareprofessionals.
ThroughtheopportunitiesprovidedbyGM’shealthandsocialcaredevolutionandthecreationofHealthInnovationManchester,wenowhaveameansofconnectinghealth,socialcare,highereducationinsight,andindustryorganisationswiththehealthandsocialcareprioritiesofourpopulation.
ThroughpartnershipworkingwithourlocalHEIsweplantodevelopGreaterManchester’sfirst‘Ed-City’.
Thisinitiativewillprovideaneducationandtrainingecosystemthatbringstogetherexpertiseineducation,bestpracticeinitiativesfromtheGreaterManchesterHealthandSocialCarePartnership,andlearninginfrastructuretoenhancetheeducationandtrainingneedsofournursingandalliedhealthprofessionalworkforce.
AddingvaluetothehealthandsocialcareprioritiesoftheGreaterManchesterpopulation,Ed-Citywillbuildbespokeprogrammesspecificallydesignedanddeliveredtomeettheevolvingneedsofournursingandalliedhealthprofessionalworkforce.
Insodoing,wewillcreatealearningenvironmentthatnotonlyattractsindividualstoourlocalUniversitiesviaauniqueeconomyofscalebutalsoprovideslife-longprofessionallearningandresearchopportunitiestoensuretheseindividualsareattheforefrontofthediscovery-carecontinuumwellintothenextmillennium.
100+ 130+People attended our Translational Research Training
Day’
Members in our Research Programme
Manager Network
13,000Participants
in our Clinical Bioinformatics online course
900NHS Trainees
undertook our 4-year DClinSci education
programme
2827
Discover Develop Deploy
InnovationandPrioritisationCommittee(IPMC):PEGmembers
wereinvolvementintheHInMInnovationandPrioritisationCom-
mittee(IPMC)workshop,todevelopthehealthandcare‘systems’
approachtoprioritisationofsystemlevelinnovations.Apublic
memberhasnownominatedandinpositionaspartoftheIPMC
Membership.
PEGmembersplayedakeypartinFuellingAmbitionCreatively
Together(FACT),thisinitiativewasdesignedforyoungpeopleto
showcasetheirideasfordigitalinnovationsintheworldofhealth.
PEGmemberssataspartofanexpertpanel,providingfeedback
andsupportforfurtherdevelopmentandrefinementofideas.
PEGmembersattendedtheHInMPatientSafety,Maternityand
NeonatalLearningSystemlauncheventtokickstartpublic
involvementandengagementagendaacrossPSCworkstreams.
ThePSCteamhavenowproducedaplanforpatientandpublic
involvementandengagementacrosstheirwork-streams.
PEGmembershavebeenworkingwiththeProgrammeManager
oftheEuropeanRegionalDevelopmentFundatHInMonHealth
2.0.Health2.0isameetupgroupfocusedoninnovationsin
thedeliveryofhealthcareandhealthrelatedtechnology.This
communityaimstoshare,discuss,showcaseanddevelopideasto
improvepatientcare.
ThedevelopmentofanEarlyDetectionandDiagnosticDementia
FrameworkforGreaterManchesterhasseenaPEGrepresentative
facilitatingandleadingdiscussionsofthePublicandInvolvement
workstream.
PEGmakeupanimportantpartofHealthInnovationManchester’s
InnovationPanel,offeringfeedbackoninnovationgrants/
applications.
PEGPublicCo-Chair(AlanCampbell)hascontinuedtoattendand
feedbackfromtheNationalAHSNInvolvementLeadsmeeting
andworkingtoinfluencethenationalagendaaroundinvolvement
andengagement
PUBLIC INVOLVEMENT AND
ENGAGEMENT IS CENTRAL TO ALL
OF OUR WORK PROGRAMMES
In 2017 / 2018 we have: Public involvement & engagement
HealthInnovationManchesterensurethatpatientandpublicvoicesareattheheartofresearchandinnovationacrosstheentiretranslationalpathway.
OurPatientExperienceGroup(PEG)continuestobeinvaluableresourcethatenablesustodeliverprogrammesandprojectswhicharegroundedinthelivedexperience.
Throughout2017/2018PEGmembershavecontinuedtobeinvolvedinawiderangeofworkunderpinnedbythefollowingobjectives:
Tobeanorganisationwhichvaluespublicinvolvementanddevelopsthecapacityandcapabilityofitsstafftoinvolve,bysupportingandpromotinginvolvementandengagement,withattentiontodiversityandinclusivity.
Toformpartnershipswithkeystakeholderstoenhanceourpublicinvolvementwork,proactivelysharingandacquiringlearningfromamongexistingnetworks.
Tomakepublicinvolvementandengagementcorebusinessbyembeddinginvolvementatalllevels.
Over2017/2018yearallHInMProgrammeLeadsandProjectsManagersreviewedtheirportfoliostomakeclearthepublicinvolvementandengagementaspectsandhavebeenfeedingthisbackinthroughthePEGgrouptoaccesstherequiredsupportforco-producingapproachestoHealthandImplementation.
PEGmembershavealsobeenworkingcloselywithHealthInnovationManchestercolleaguestohighlightingtheimportantofthePP&Eagendaandsupporttheorganisationtoworktowardsatrueco-productionmodel-whichisHealthInnovationManchester’sambition.
100+ 130+People attended our Translational Research Training
Day’
Members in our Research Programme
Manager Network
13,000Participants
in our Clinical Bioinformatics online course
900NHS Trainees
undertook our 4-year DClinSci education
programme
3029
Discover Develop Deploy
MEETTHEHEALTHINNOVATIONMANCHESTERBOARD
Professor Ben Bridgewater
Chief Executive Officer -
Health Innovation Manchester
Sir David Dalton
Chief Executive
Salford Royal NHS Foundation Trust and Pennine Acute
Hospitals NHS Trust
Sir Mike Deegan
Chief Executive
Manchester University NHS Foundation Trust
Johnny Lundgren
Chair
Greater Manchester Academic Health Science Network
Dr Kiran Patel
Chair
Association of Greater Manchester Clinical
Commissioning Groups
Jon Rouse
Chief Officer
Greater Manchester Health and Social Care Partnership
Lord Peter Smith
Greater Manchester Combined Authority Leader
with responsability for Health and Social Care
Roger Spencer
Chief Executive
Christie NHS Foundation Trust, Chair of Clinical Research
Network
Malcolm Press
Vice Chancellor
Manchester Metropolitan University
Rowena Burns
Chair Health Innovation Manchester
Chief Executive Manchester Science
Partnerships
John Stageman
Chair
Bionow
Dame Nancy Rothwell
President
University of Manchester
Richard Topliss
Chair
Manchester Growth Company
Sir Howard Bernstein
Chair
GM Strategic Partnership Board and Manchester Academic
Health Science Centre
Ian Greer
Vice President of the University of Manchester
Dean - Faculty of Biology, Medicine & Health
www.healthinnovationmanchester.com
@healthinnovmcr
TheHealthInnovationManchesterboardbringstogetherawealthofexperience,expertiseandinsightfromNHSandsocialcare,academiaandindustry.
32
Amanda Risino
Managing Director
Greater Manchester Academic Health Science Network
Discover Develop Deploy
FINANCIALPOSITION2017/2018
GMAHSN MAHSC HInM
£’000s £’000s £’000s
INCOME 5,700 1,164 6,865
EXPENDITURE
Health and Implementation 856 0 856
Informatics 454 0 454
Industry and Wealth 1,086 0 1,086
Utilisation Management 1,233 0 1,233
Research and Development 184 345 529
Research Domains 0 639 639
Corporate 1,082 141 1,943
TOTAL EXPENDITURE 5,615 1,125 6,740
NET SURPLUS 85 40 125
NOTES:
GMAHSN results are for the year ended 31 March 2018
MAHSC results are for the period 01 August 2017 to 31 March 2018
Health Innovation Manchester,Third Floor,
Citylabs,Nelson Street,
ManchesterM13 9NQ
t 0161 509 3840w: healthinnovationmanchester.com
33